[A clinical study on an antagonist of angiotensin II. Application to diagnosis and pharmacological treatment (author's transl)]. 1977

M Yasujima, and K Abe, and K Ritsu, and H Aoyagi, and N Irokawa

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

M Yasujima, and K Abe, and K Ritsu, and H Aoyagi, and N Irokawa
June 1999, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
M Yasujima, and K Abe, and K Ritsu, and H Aoyagi, and N Irokawa
June 1974, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
M Yasujima, and K Abe, and K Ritsu, and H Aoyagi, and N Irokawa
April 1981, Nihon Gan Chiryo Gakkai shi,
M Yasujima, and K Abe, and K Ritsu, and H Aoyagi, and N Irokawa
November 1978, Nihon Naibunpi Gakkai zasshi,
M Yasujima, and K Abe, and K Ritsu, and H Aoyagi, and N Irokawa
June 1979, Ryumachi. [Rheumatism],
M Yasujima, and K Abe, and K Ritsu, and H Aoyagi, and N Irokawa
January 1979, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
M Yasujima, and K Abe, and K Ritsu, and H Aoyagi, and N Irokawa
October 1979, Nihon rinsho. Japanese journal of clinical medicine,
M Yasujima, and K Abe, and K Ritsu, and H Aoyagi, and N Irokawa
January 1980, Kekkaku : [Tuberculosis],
M Yasujima, and K Abe, and K Ritsu, and H Aoyagi, and N Irokawa
January 1974, Nihon Koku Geka Gakkai zasshi,
M Yasujima, and K Abe, and K Ritsu, and H Aoyagi, and N Irokawa
February 1995, European journal of pharmacology,
Copied contents to your clipboard!